Dataset Information

PPAR-? as a key nutritional and environmental sensor for metabolic adaptation.

ABSTRACT: Peroxisome proliferator-activated receptors (PPARs) are transcription factors that belong to the superfamily of nuclear hormone receptors and regulate the expression of several genes involved in metabolic processes that are potentially linked to the development of some diseases such as hyperlipidemia, diabetes, and obesity. One type of PPAR, PPAR-?, is a transcription factor that regulates the metabolism of lipids, carbohydrates, and amino acids and is activated by ligands such as polyunsaturated fatty acids and drugs used to treat dyslipidemias. There is evidence that genetic variants within the PPAR? gene have been associated with a risk of the development of dyslipidemia and cardiovascular disease by influencing fasting and postprandial lipid concentrations; the gene variants have also been associated with an acceleration of the progression of type 2 diabetes. The interactions between genetic PPAR? variants and the response to dietary factors will help to identify individuals or populations who can benefit from specific dietary recommendations. Interestingly, certain nutritional conditions, such as the prolonged consumption of a protein-restricted diet, can produce long-lasting effects on PPAR? gene expression through modifications in the methylation of a specific locus surrounding the PPAR? gene. Thus, this review underlines our current knowledge about the important role of PPAR-? as a mediator of the metabolic response to nutritional and environmental factors.

SUBMITTER: Contreras AV

PROVIDER: S-EPMC3941823 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

Contreras Alejandra V AV Torres Nimbe N Tovar Armando R AR

Advances in nutrition (Bethesda, Md.) 20130701 4

Peroxisome proliferator-activated receptors (PPARs) are transcription factors that belong to the superfamily of nuclear hormone receptors and regulate the expression of several genes involved in metabolic processes that are potentially linked to the development of some diseases such as hyperlipidemia, diabetes, and obesity. One type of PPAR, PPAR-α, is a transcription factor that regulates the metabolism of lipids, carbohydrates, and amino acids and is activated by ligands such as polyunsaturate ...[more]

PMID: 23858092

Similar Datasets

Project description:BACKGROUND & AIMS:Although the role of inflammation to combat infection is known, the contribution of metabolic changes in response to sepsis is poorly understood. Sepsis induces the release of lipid mediators, many of which activate nuclear receptors such as the peroxisome proliferator-activated receptor (PPAR)?, which controls both lipid metabolism and inflammation. We aimed to elucidate the previously unknown role of hepatic PPAR? in the response to sepsis. METHODS:Sepsis was induced by intraperitoneal injection of Escherichia coli in different models of cell-specific Ppara-deficiency and their controls. The systemic and hepatic metabolic response was analyzed using biochemical, transcriptomic and functional assays. PPAR? expression was analyzed in livers from elective surgery and critically ill patients and correlated with hepatic gene expression and blood parameters. RESULTS:Both whole body and non-hematopoietic Ppara-deficiency in mice decreased survival upon bacterial infection. Livers of septic Ppara-deficient mice displayed an impaired metabolic shift from glucose to lipid utilization resulting in more severe hypoglycemia, impaired induction of hyperketonemia and increased steatosis due to lower expression of genes involved in fatty acid catabolism and ketogenesis. Hepatocyte-specific deletion of PPAR? impaired the metabolic response to sepsis and was sufficient to decrease survival upon bacterial infection. Hepatic PPARA expression was lower in critically ill patients and correlated positively with expression of lipid metabolism genes, but not with systemic inflammatory markers. CONCLUSION:During sepsis, Ppara-deficiency in hepatocytes is deleterious as it impairs the adaptive metabolic shift from glucose to FA utilization. Metabolic control by PPAR? in hepatocytes plays a key role in the host defense against infection. LAY SUMMARY:As the main cause of death in critically ill patients, sepsis remains a major health issue lacking efficacious therapies. While current clinical literature suggests an important role for inflammation, metabolic aspects of sepsis have mostly been overlooked. Here, we show that mice with an impaired metabolic response, due to deficiency of the nuclear receptor PPAR? in the liver, exhibit enhanced mortality upon bacterial infection despite a similar inflammatory response, suggesting that metabolic interventions may be a viable strategy for improving sepsis outcomes.

Project description:Low-cost sensors enable finer-scale spatiotemporal measurements within the existing methane (CH4) monitoring infrastructure and could help cities mitigate CH4 emissions to meet their climate goals. While initial studies of low-cost CH4 sensors have shown potential for effective CH4 measurement at ambient concentrations, sensor deployment remains limited due to questions about interferences and calibration across environments and seasons. This study evaluates sensor performance across seasons with specific attention paid to the sensor's understudied carbon monoxide (CO) interferences and environmental dependencies through long-term ambient co-location in an urban environment. The sensor was first evaluated in a laboratory using chamber calibration and co-location experiments, and then in the field through two 8 week co-locations with a reference CH4 instrument. In the laboratory, the sensor was sensitive to CH4 concentrations below ambient background concentrations. Different sensor units responded similarly to changing CH4, CO, temperature, and humidity conditions but required individual calibrations to account for differences in sensor response factors. When deployed in-field, co-located with a reference instrument near Baltimore, MD, the sensor captured diurnal trends in hourly CH4 concentration after corrections for temperature, absolute humidity, CO concentration, and hour of day. Variable performance was observed across seasons with the sensor performing well (R 2 = 0.65; percent bias 3.12%; RMSE 0.10 ppm) in the winter validation period and less accurately (R 2 = 0.12; percent bias 3.01%; RMSE 0.08 ppm) in the summer validation period where there was less dynamic range in CH4 concentrations. The results highlight the utility of sensor deployment in more variable ambient CH4 conditions and demonstrate the importance of accounting for temperature and humidity dependencies as well as co-located CO concentrations with low-cost CH4 measurements. We show this can be addressed via Multiple Linear Regression (MLR) models accounting for key covariates to enable urban measurements in areas with CH4 enhancement. Together with individualized calibration prior to deployment, the sensor shows promise for use in low-cost sensor networks and represents a valuable supplement to existing monitoring strategies to identify CH4 hotspots.

Project description:The transcription factor FoxO1 contributes to the metabolic adaptation to fasting by suppressing muscle oxidation of glucose, sparing it for glucose-dependent tissues. Previously, we reported that FoxO1 activation in C(2)C(12) muscle cells recruits the fatty acid translocase CD36 to the plasma membrane and increases fatty acid uptake and oxidation. This, together with FoxO1 induction of lipoprotein lipase, would promote the reliance on fatty acid utilization characteristic of the fasted muscle. Here, we show that CD36-mediated fatty acid uptake, in turn, up-regulates protein levels and activity of FoxO1 as well as its target PDK4, the negative regulator of glucose oxidation. Increased fatty acid flux or enforced CD36 expression in C(2)C(12) cells is sufficient to induce FoxO1 and PDK4, whereas CD36 knockdown has opposite effects. In vivo, CD36 loss blunts fasting induction of FoxO1 and PDK4 and the associated suppression of glucose oxidation. Importantly, CD36-dependent regulation of FoxO1 is mediated by the nuclear receptor PPARdelta/beta. Loss of PPARdelta/beta phenocopies CD36 deficiency in blunting fasting induction of muscle FoxO1 and PDK4 in vivo. Expression of PPARdelta/beta in C(2)C(12) cells, like that of CD36, robustly induces FoxO1 and suppresses glucose oxidation, whereas co-expression of a dominant negative PPARdelta/beta compromises FoxO1 induction. Finally, several PPRE sites were identified in the FoxO1 promoter, which was responsive to PPARdelta/beta. Agonists of PPARdelta/beta were sufficient to confer responsiveness and transactivate the heterologous FoxO1 promoter but not in the presence of dominant negative PPARdelta/beta. Taken together, our findings suggest that CD36-dependent FA activation of PPARdelta/beta results in the transcriptional regulation of FoxO1 as well as PDK4, recently shown to be a direct PPARdelta/beta target. FoxO1 in turn can regulate CD36, lipoprotein lipase, and PDK4, reinforcing the action of PPARdelta/beta to increase muscle reliance on FA. The findings could have implications in the chronic abnormalities of fatty acid metabolism associated with obesity and diabetes.

Dataset Information

PPAR-? as a key nutritional and environmental sensor for metabolic adaptation.

Publications

PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets